WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on TGTX, TRVN, VNDA, and VSTM which can be accessed for free by signing up to www.wallstequities.com/registration. On …
KHNL · 27d
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on TGTX, TRVN, VNDA, and VSTM which can be accessed for free by signing up to www.wallstequities.com/registration. On …
WSFA · 27d
Vanda Pharmaceut (NASDAQ:VNDA) traded in a range yesterday that spanned from a low of $15.38 to a high of $16.50. Yesterday, the shares fell 5.2%, which took the trading range below the 3-day low of $16.10 on volume of 529,000 shares. Often times after ...
SmarTrend · 1mon
Vanda Pharmaceuticals Inc : Vanda pharmaceuticals reports second quarter 2016 financial results . Vanda reiterates 2016 net product sales guidance of $143 million to $153 million . Qtrly loss per share $0.11; revenue $36.03 million . Says reiterates its ...
Reuters · 1y
Investors eagerly wait for updates on the pipelines of biopharma/biotech companies. Such updates including label expansions of marketed products help them to decide whether or not to invest in a particular company. Pipeline updates provide information on ...
Nasdaq · 4y
Vanda Pharmaceuticals Inc :U.S. District Court ruled that Roxane Laboratories infringed U.S. patent nos. RE39,198 and 8,586,610 by submitting to FDA an ANDA.
Reuters · 1y
Specifically, the stock lost 6.8% during this period, compared with the 5.5% drop for the industry. Note that Biogen has declared a special dividend distribution of all of the outstanding shares of Bioverativ common stock. Biogen's stockholders of record ...
Nasdaq · 1y